ema tirzepatide EU regulator recommends expanding Mounjaro approval to obesity EMA's committee says expanded label

In biochemical and preclinical research systems, GLP-RT interacts with three class B G protein-coupled receptors that regulate metabolic signaling networks: GLP-1R, GIPR, and GCGR

This treatment reduces cravings and promotes fat loss for sustainable, long-term results.

Discover evidence-based calorie targets, minimum intake guidelines, nutrition strategies, and warning signs of undereating while taking this GLP-1 medication for safe, effective weight loss.

What is tested: Average Blood Sugar:A key indicator of metabolic health and risk factor for developing diabetes, measured by hbA1c

Learn how we can help you develop products to support GI comfort, muscle health, hydration, and more for consumers engaging with GLP-1 medications.

Starting in mid-2026, Medicare will begin covering these drugs for select patient groups and state Medicaid programs have the option to adopt similar coverage at these discounted rates